4//SEC Filing
Tak Paul Peter 4
Accession 0000950170-25-021283
CIK 0001841387other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:30 PM ET
Size
17.6 KB
Accession
0000950170-25-021283
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-12+525,000→ 525,000 totalExercise: $8.55Exp: 2035-02-12→ Common Stock (525,000 underlying)
Footnotes (1)
- [F1]This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following February 12, 2025, subject to the Reporting Person's continued service on each vesting date.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873905
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:30 PM ET
- Size
- 17.6 KB